Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.

<h4>Objective</h4>The aim of this study was to use spoligotyping and large sequence polymorphism (LSP) to study the population structure of M. tuberculosis complex (MTBC) isolates.<h4>Methods</h4>MTBC isolates were identified using standard biochemical procedures, IS6110 PCR,...

Full description

Bibliographic Details
Main Authors: Dorothy Yeboah-Manu, Adwoa Asante-Poku, Thomas Bodmer, David Stucki, Kwadwo Koram, Frank Bonsu, Gerd Pluschke, Sebastien Gagneux
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21779354/?tool=EBI
_version_ 1819126703892463616
author Dorothy Yeboah-Manu
Adwoa Asante-Poku
Thomas Bodmer
David Stucki
Kwadwo Koram
Frank Bonsu
Gerd Pluschke
Sebastien Gagneux
author_facet Dorothy Yeboah-Manu
Adwoa Asante-Poku
Thomas Bodmer
David Stucki
Kwadwo Koram
Frank Bonsu
Gerd Pluschke
Sebastien Gagneux
author_sort Dorothy Yeboah-Manu
collection DOAJ
description <h4>Objective</h4>The aim of this study was to use spoligotyping and large sequence polymorphism (LSP) to study the population structure of M. tuberculosis complex (MTBC) isolates.<h4>Methods</h4>MTBC isolates were identified using standard biochemical procedures, IS6110 PCR, and large sequence polymorphisms. Isolates were further typed using spoligotyping, and the phenotypic drug susceptibility patterns were determined by the proportion method.<h4>Result</h4>One hundred and sixty-two isolates were characterised by LSP typing. Of these, 130 (80.25%) were identified as Mycobacterium tuberculosis sensu stricto (MTBss), with the Cameroon sub-lineage being dominant (N = 59/130, 45.38%). Thirty-two (19.75%) isolates were classified as Mycobacterium africanum type 1, and of these 26 (81.25%) were identified as West-Africa I, and 6 (18.75%) as West-Africa II. Spoligotyping sub-lineages identified among the MTBss included Haarlem (N = 15, 11.53%), Ghana (N = 22, 16.92%), Beijing (4, 3.08%), EAI (4, 3.08%), Uganda I (4, 3.08%), LAM (2, 1.54%), X (N = 1, 0.77%) and S (2, 1.54%). Nine isolates had SIT numbers with no identified sub-lineages while 17 had no SIT numbers. MTBss isolates were more likely to be resistant to streptomycin (p<0.008) and to any drug resistance (p<0.03) when compared to M. africanum.<h4>Conclusion</h4>This study demonstrated that overall 36.4% of TB in South-Western Ghana is caused by the Cameroon sub-lineage of MTBC and 20% by M. africanum type 1, including both the West-Africa 1 and West-Africa 2 lineages. The diversity of MTBC in Ghana should be considered when evaluating new TB vaccines.
first_indexed 2024-12-22T08:00:15Z
format Article
id doaj.art-727324ebd1e44f6784e3cbfa84567a9c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T08:00:15Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-727324ebd1e44f6784e3cbfa84567a9c2022-12-21T18:33:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0167e2190610.1371/journal.pone.0021906Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.Dorothy Yeboah-ManuAdwoa Asante-PokuThomas BodmerDavid StuckiKwadwo KoramFrank BonsuGerd PluschkeSebastien Gagneux<h4>Objective</h4>The aim of this study was to use spoligotyping and large sequence polymorphism (LSP) to study the population structure of M. tuberculosis complex (MTBC) isolates.<h4>Methods</h4>MTBC isolates were identified using standard biochemical procedures, IS6110 PCR, and large sequence polymorphisms. Isolates were further typed using spoligotyping, and the phenotypic drug susceptibility patterns were determined by the proportion method.<h4>Result</h4>One hundred and sixty-two isolates were characterised by LSP typing. Of these, 130 (80.25%) were identified as Mycobacterium tuberculosis sensu stricto (MTBss), with the Cameroon sub-lineage being dominant (N = 59/130, 45.38%). Thirty-two (19.75%) isolates were classified as Mycobacterium africanum type 1, and of these 26 (81.25%) were identified as West-Africa I, and 6 (18.75%) as West-Africa II. Spoligotyping sub-lineages identified among the MTBss included Haarlem (N = 15, 11.53%), Ghana (N = 22, 16.92%), Beijing (4, 3.08%), EAI (4, 3.08%), Uganda I (4, 3.08%), LAM (2, 1.54%), X (N = 1, 0.77%) and S (2, 1.54%). Nine isolates had SIT numbers with no identified sub-lineages while 17 had no SIT numbers. MTBss isolates were more likely to be resistant to streptomycin (p<0.008) and to any drug resistance (p<0.03) when compared to M. africanum.<h4>Conclusion</h4>This study demonstrated that overall 36.4% of TB in South-Western Ghana is caused by the Cameroon sub-lineage of MTBC and 20% by M. africanum type 1, including both the West-Africa 1 and West-Africa 2 lineages. The diversity of MTBC in Ghana should be considered when evaluating new TB vaccines.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21779354/?tool=EBI
spellingShingle Dorothy Yeboah-Manu
Adwoa Asante-Poku
Thomas Bodmer
David Stucki
Kwadwo Koram
Frank Bonsu
Gerd Pluschke
Sebastien Gagneux
Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
PLoS ONE
title Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
title_full Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
title_fullStr Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
title_full_unstemmed Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
title_short Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.
title_sort genotypic diversity and drug susceptibility patterns among m tuberculosis complex isolates from south western ghana
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21779354/?tool=EBI
work_keys_str_mv AT dorothyyeboahmanu genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT adwoaasantepoku genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT thomasbodmer genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT davidstucki genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT kwadwokoram genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT frankbonsu genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT gerdpluschke genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana
AT sebastiengagneux genotypicdiversityanddrugsusceptibilitypatternsamongmtuberculosiscomplexisolatesfromsouthwesternghana